ArticleThe oncologist2025
Supporting our survivors: an evaluation of the facilitators and barriers to advocacy in cervical and breast cancer survivors.
Article in The oncologist, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Barriers and opportunities for participation in health policy decision-making by civil society groups organized for cancer in Chile: a qualitative study.Health research policy and systems · 2026Article
- "Don't settle": Rural cervical cancer survivors' navigation of cancer care from an intersectional framework.Women's health (London, England)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to evaluate the facilitators and barriers to self-advocacy and advocacy in the community of cervical and breast cancer survivors.
methodsA mixed-methods approach was used to collect data from patients with breast and cervical cancer. Qualitative interviews were conducted after presenting for routine oncologic follow-up appointments All interviews were transcribed and coded by two separate investigators. The Female Self-Advocacy in Cancer Survivorship Scale (FSACS) was administered and demographic data were collected to quantitatively evaluate self-advocacy behaviors and socioeconomic characteristics in the two groups.
resultsTwenty-one patients were interviewed: 11 cervical cancer (CC) patients and 10 breast cancer (BC) patients. The median age was 47 years, with approximately half having early-stage disease and half having advanced or recurrent disease. The facilitators to self-advocacy included being open with their support system, wanting more information, and being determined to fight. Barriers to self-advocacy included fear, not opening up to family and friends, and not wanting additional information. Facilitators to advocacy in the community were talking with their children about their diagnosis, having an interest in support groups, and a desire to help. Barriers to community advocacy included not always feeling supported, a lack of confidence, and a lack of understanding of their disease process. CC participants scored lower on the FSACS survey compared to BC patients, with mean scores of 95 and 107, respectively.
conclusionsFacilitators to advocacy involve having a strong social network and a determination to fight or desire to help. Barriers include fear, lack of confidence, and lack of knowledge. Increasing resources to encourage social connection, education, and advocacy opportunities can positively impact cancer survivors well-being.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.